Home › Funds › FRONTIER CAPITAL MANAGEMENT CO LLC › KYMR
FRONTIER CAPITAL MANAGEMENT CO LLC position in KYMR
KYMERA THERAPEUTICS INC · Health Care
FRONTIER CAPITAL MANAGEMENT CO LLC reported holding 740,866 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$85.0M, representing 0.79% of its reported portfolio and ranking #27 among its reported holdings. FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed KYMR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How FRONTIER CAPITAL MANAGEMENT CO LLC's KYMR position evolved
FRONTIER CAPITAL MANAGEMENT CO LLC first disclosed a stake in KYMR in Q3 2024 at 392,263 shares (US$18.6M). The position peaked in Q2 2026 at 740,866 shares, worth US$85.0M. Across 8 filings, FRONTIER CAPITAL MANAGEMENT CO LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 740,866 shares valued at US$85.0M — a reduction of -18,982 shares quarter over quarter.. Notable position changes include a 62% trim in Q4 2024 (shares fell 32% over the following quarter), a 273% increase in Q2 2025 (shares rose 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 392.26K | $18.57M | New |
| Q4 2024 | 150.17K | $6.04M | Reduce |
| Q1 2025 | 131.96K | $3.61M | Reduce |
| Q2 2025 | 491.81K | $21.46M | Add |
| Q3 2025 | 518.06K | $29.32M | Add |
| Q4 2025 | 635.96K | $49.48M | Add |
| Q1 2026 | 759.85K | $63.29M | Add |
| Q2 2026 | 740.87K | $84.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M sh · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- BVF INC/IL 3.87M sh · $444.01M · Q2 2026
- Siren, L.L.C. 2.94M sh · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K sh · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K sh · $88.54M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K sh · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K sh · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
- BRAIDWELL LP 378.16K sh · $43.36M · Q2 2026
More on FRONTIER CAPITAL MANAGEMENT CO LLC
FAQ
How long has FRONTIER CAPITAL MANAGEMENT CO LLC held KYMR?
FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed KYMR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is FRONTIER CAPITAL MANAGEMENT CO LLC's current position in KYMR?
As of Q2 2026, FRONTIER CAPITAL MANAGEMENT CO LLC holds 740.87K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $84.96M, representing 0.79% of its reported portfolio and ranking #27.
Has FRONTIER CAPITAL MANAGEMENT CO LLC been buying or selling KYMR?
In the latest 13F filing (Q2 2026), FRONTIER CAPITAL MANAGEMENT CO LLC reduced its position in KYMR. The position peaked in Q2 2026 at 740.87K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.